文献速递临床试验与 GCP基础与转化研究

COMPEX试验:计算机化认知康复改善卒中、心脏骤停或帕金森病患者执行功能对比非特异性训练的研究方案

The COMPEX-trial: computer-based cognitive rehabilitation to improve executive function versus unspecific training in patients after stroke, cardiac arrest or in Parkinson's disease: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-03-19

COMPEX试验是一项多中心、研究者发起的、单盲、优效性随机对照试验,计划纳入308例卒中、心脏骤停或帕金森病伴工作记忆受损的成人患者,随机分配至特异性计算机化认知康复(CBCR)组或主动对照组,干预8周,主要结局为CABPad评估的工作记忆,旨在验证CBCR对执行功能的改善效果。

要点

  • CBCR是一种低成本干预,可能改善卒中、心脏骤停或帕金森病患者的工作记忆。
  • 试验采用单盲、优效性设计,比较特异性CBCR与一般计算机认知活动。
  • 主要结局为CABPad评估的工作记忆,干预为期8周。

核心结论

  • 该试验将提供CBCR增强执行功能有效性的证据,可能指导未来临床实施。

研究设计与样本

  • 多中心、研究者发起的、优效性随机对照试验,采用单盲设计。
  • 计划纳入308例参与者,基于统计功效计算;目前已有291例患者入组。
  • 参与者为≥18岁、卒中、心脏骤停或帕金森病后工作记忆受损的患者,按1:1随机分配至特异性CBCR组或主动对照组。

关键数值与推荐

  • 主要结局为CABPad评估的工作记忆。
  • 次要结局包括工具性日常生活活动、情绪、焦虑和生活质量测量。

临床怎么用

  • 若证实有效,CBCR可作为低成本康复手段用于卒中、心脏骤停或帕金森病患者的工作记忆改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Impairment of the executive functions can be reduced by training, but most traditional approaches require specialized expertise. Therefore, cognitive rehabilitation is only offered to a minority of patients with a need. Computer-based Cognitive Rehabilitation (CBCR) is a low-cost intervention with rehabilitation potential. Outside of hospital rehabilitation institutions, the work is based on dysfunctions and not diagnoses, why patients after stroke, cardiac arrest, or in Parkinson's disease were included based on their dysfunctions with the aim of potential broad implementation. AIM AND HYPOTHESIS: This trial investigates whether specific CBCR focusing on executive functions is superior to general computer-based cognitive activities in improving working memory. SAMPLE SIZE ESTIMATES: Based on a statistical power calculation, 308 participants will be enrolled. A total of 291 patients are currently included in the trial. METHODS AND DESIGN: The trial is a multi-center, investigator-initiated, superiority randomized controlled trial with single blinding. Participants (≥ 18 years) with impaired working memory following stroke, cardiac arrest, or Parkinson's disease will be randomized (1:1) to either specific CBCR using Scientific BrainTraining Pro (Happy Neuron) or an active control group performing unspecific cognitive activities. The intervention lasts eight weeks (60 min/day, 5 days/week). Six centers are involved in the trial and completion of inclusion is expected in November 2025. STUDY OUTCOME(S): The primary outcome is working memory, assessed by CABPad. Secondary outcomes include instrumental activities of daily living, mood, anxiety, and quality of life measures. DISCUSSION: This trial will provide evidence on the efficacy of CBCR in enhancing executive functions, potentially guiding future clinical implementation. TRIAL REGISTRATION: The trial is registered at Clinicaltrials.gov with identifier: NCT04229056. Registered on January 6, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sværke K, Christensen L, Løkkegaard A, et al. The COMPEX-trial: computer-based cognitive rehabilitation to improve executive function versus unspecific training in patients after stroke, cardiac arrest or in Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2026. PMID: 41857604. doi:10.1186/s13063-026-09623-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。